Steffen B. Wiegand

852 total citations
27 papers, 506 citations indexed

About

Steffen B. Wiegand is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Steffen B. Wiegand has authored 27 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 10 papers in Epidemiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Steffen B. Wiegand's work include Hepatitis C virus research (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis B Virus Studies (8 papers). Steffen B. Wiegand is often cited by papers focused on Hepatitis C virus research (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis B Virus Studies (8 papers). Steffen B. Wiegand collaborates with scholars based in Germany, United States and Poland. Steffen B. Wiegand's co-authors include Markus Cornberg, Heiner Wedemeyer, Michael P. Manns, Benjamin Maasoumy, Katja Deterding, Jerzy Jaroszewicz, Birgit Bremer, Patrick Lehmann, Warren M. Zapol and Christoph Höner zu Siederdissen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Steffen B. Wiegand

22 papers receiving 498 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Steffen B. Wiegand 342 314 54 39 37 27 506
Soňa Fraňková 193 0.6× 174 0.6× 73 1.4× 16 0.4× 17 0.5× 50 364
Emma Castro 52 0.2× 165 0.5× 60 1.1× 15 0.4× 25 0.7× 19 386
S Kashiwagi 127 0.4× 210 0.7× 41 0.8× 11 0.3× 44 1.2× 28 372
Kohachiro Sugiyama 263 0.8× 284 0.9× 144 2.7× 15 0.4× 49 1.3× 38 621
S. Hadziyannis 981 2.9× 1.0k 3.3× 87 1.6× 8 0.2× 53 1.4× 55 1.2k
Tao Bian 56 0.2× 149 0.5× 39 0.7× 56 1.4× 102 2.8× 24 336
Ergenekon Karagöz 60 0.2× 103 0.3× 33 0.6× 14 0.4× 24 0.6× 39 189
Benoît Flan 207 0.6× 66 0.2× 220 4.1× 6 0.2× 110 3.0× 17 455
Zachary R. Barbati 41 0.1× 86 0.3× 77 1.4× 10 0.3× 54 1.5× 9 330
Qing‐He Nie 95 0.3× 104 0.3× 66 1.2× 15 0.4× 75 2.0× 31 320

Countries citing papers authored by Steffen B. Wiegand

Since Specialization
Citations

This map shows the geographic impact of Steffen B. Wiegand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen B. Wiegand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen B. Wiegand more than expected).

Fields of papers citing papers by Steffen B. Wiegand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffen B. Wiegand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen B. Wiegand. The network helps show where Steffen B. Wiegand may publish in the future.

Co-authorship network of co-authors of Steffen B. Wiegand

This figure shows the co-authorship network connecting the top 25 collaborators of Steffen B. Wiegand. A scholar is included among the top collaborators of Steffen B. Wiegand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffen B. Wiegand. Steffen B. Wiegand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simons, J., Steffen B. Wiegand, Rüdger Kopp, et al.. (2025). Extubation in the operating room after elective on-pump CABG surgery: impact on patient outcome and clinical practice during the COVID-19 pandemic. Indian Journal of Thoracic and Cardiovascular Surgery. 41(7). 863–873.
2.
3.
Wiegand, Steffen B., et al.. (2024). The Ventilatory Ratio as a Predictor of Successful Weaning from a Veno-Venous Extracorporeal Membrane Oxygenator. Journal of Clinical Medicine. 13(13). 3758–3758.
4.
Simons, J., Steffen B. Wiegand, Rüdger Kopp, et al.. (2024). Early extubation after elective surgical aortic valve replacement during the COVID-19 pandemic. Journal of Cardiothoracic Surgery. 19(1). 490–490.
5.
Wiegand, Steffen B., Michael Paal, Jette Jung, et al.. (2024). Importance of the neutrophil-to-lymphocyte ratio as a marker for microbiological specimens in critically ill patients after liver or lung transplantation. Infection. 53(2). 573–582. 2 indexed citations
6.
Traeger, Lisa, William A. Farinelli, Steffen B. Wiegand, et al.. (2021). Hyperbaric phototherapy augments blood carbon monoxide removal. Lasers in Surgery and Medicine. 54(3). 426–432. 4 indexed citations
7.
Wiegand, Steffen B., L. Zazzeron, Lisa Traeger, et al.. (2021). Veno‐venous extracorporeal blood phototherapy increases the rate of carbon monoxide (CO) elimination in CO‐poisoned pigs. Lasers in Surgery and Medicine. 54(2). 256–267. 9 indexed citations
8.
Traeger, Lisa, Steffen B. Wiegand, Andrew J. Sauer, et al.. (2021). UBA6 and NDFIP1 regulate the degradation of ferroportin. Haematologica. 107(2). 478–488. 20 indexed citations
9.
10.
Yu, Binglan, Francesco Zadek, Steffen B. Wiegand, et al.. (2020). Intratracheal injection of nitric oxide, generated from air by pulsed electrical discharge, for the treatment of pulmonary hypertension in awake ambulatory lambs. Nitric Oxide. 97. 11–15. 3 indexed citations
11.
Wiegand, Steffen B., Lisa Traeger, Francesco Zadek, et al.. (2020). Antimicrobial effects of nitric oxide in murine models of Klebsiella pneumonia. Redox Biology. 39. 101826–101826. 39 indexed citations
12.
Wiegand, Steffen B., Anika Wranke, Jerzy Jaroszewicz, et al.. (2019). Soluble immune markers in the different phases of chronic hepatitis B virus infection. Scientific Reports. 9(1). 14118–14118. 23 indexed citations
13.
Bremer, Corinna M., Katrin Schröder, Steffen B. Wiegand, et al.. (2019). Quantitation of large, middle and small hepatitis B surface proteins in HBeAg‐positive patients treated with peginterferon alfa‐2a. Liver International. 40(2). 324–332. 12 indexed citations
14.
Siederdissen, Christoph Höner zu, Benjamin Maasoumy, Steffen B. Wiegand, et al.. (2016). Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B. The Journal of Infectious Diseases. 214(10). 1492–1497. 92 indexed citations
15.
Wiegand, Steffen B., Jerzy Jaroszewicz, Andrej Potthoff, et al.. (2015). Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10 levels in HBV/HCV-coinfected patients. Clinical Microbiology and Infection. 21(7). 710.e1–710.e9. 40 indexed citations
16.
Maasoumy, Benjamin, Steffen B. Wiegand, Jerzy Jaroszewicz, et al.. (2015). Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D. Clinical Microbiology and Infection. 21(6). 606.e1–606.e10. 111 indexed citations
17.
Pischke, Sven, Carolynne Schwarze‐Zander, Birgit Bremer, et al.. (2015). Hepatitis E Virus Seroprevalence Rate in HIV-Infected Patients in Germany: A Comparison of Two Commercial Assays. Intervirology. 58(5). 283–287. 11 indexed citations
18.
Wiegand, Steffen B., Benjamin Heidrich, S. Süsser, et al.. (2015). Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting. PLoS ONE. 10(12). e0145622–e0145622. 2 indexed citations
19.
Pischke, Sven, A. Gisa, Pothakamuri Venkata Suneetha, et al.. (2014). Increased HEV Seroprevalence in Patients with Autoimmune Hepatitis. PLoS ONE. 9(1). e85330–e85330. 56 indexed citations
20.
Heidrich, Benjamin, Steffen B. Wiegand, Peter Buggisch, et al.. (2014). Treatment of Naïve Patients with Chronic Hepatitis C Genotypes 2 and 3 with Pegylated Interferon Alpha and Ribavirin in a Real World Setting: Relevance for the New Era of DAA. PLoS ONE. 9(10). e108751–e108751. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soňa Fraňková Breakdown of academic impact, for papers by Emma Castro Breakdown of academic impact, for papers by S Kashiwagi Breakdown of academic impact, for papers by Kohachiro Sugiyama Breakdown of academic impact, for papers by S. Hadziyannis Breakdown of academic impact, for papers by Tao Bian Breakdown of academic impact, for papers by Ergenekon Karagöz Breakdown of academic impact, for papers by Benoît Flan Breakdown of academic impact, for papers by Zachary R. Barbati Breakdown of academic impact, for papers by Qing‐He Nie
Rankless by CCL
2026